315 related articles for article (PubMed ID: 24067337)
1. Methacholine bronchial challenge effects on nasal symptoms and function in patients with allergic rhinitis.
Cirillo I; Medusei G; Signori A; Ciprandi G
Eur Ann Allergy Clin Immunol; 2013 Aug; 45(4):123-9. PubMed ID: 24067337
[TBL] [Abstract][Full Text] [Related]
2. Allergic rhinitis phenotypes based on bronchial hyperreactivity to methacholine.
Ciprandi G; Ricciardolo FL; Schiavetti I; Cirillo I
Am J Rhinol Allergy; 2014; 28(6):214-8. PubMed ID: 25514477
[TBL] [Abstract][Full Text] [Related]
3. Pulmonary function parameters in patients with allergic rhinitis.
Bavbek S; Saryal S; Karabiyikoglu G; Misirligil Z
J Investig Allergol Clin Immunol; 2003; 13(4):252-8. PubMed ID: 14989114
[TBL] [Abstract][Full Text] [Related]
4. Effect of intranasal triamcinolone acetonide on bronchial hyper-responsiveness in children with seasonal allergic rhinitis and comparison of perceptional nasal obstruction with acoustic rhinometric assessment.
Oztürk F; Türktaş I; Asal K; Ileri F; Münevver Pinar N
Int J Pediatr Otorhinolaryngol; 2004 Aug; 68(8):1007-15. PubMed ID: 15236886
[TBL] [Abstract][Full Text] [Related]
5. Relationship between airway sensitivity to adenosine 5' monophosphate and the shape of the concentration-response curve to methacholine in subjects with allergic rhinitis.
Prieto L; Gutiérrez V; Marín J
Respir Med; 2001 Jun; 95(6):457-63. PubMed ID: 11421502
[TBL] [Abstract][Full Text] [Related]
6. Allergic rhinitis with hyper-responsiveness differ from asthma in degree of peripheral obstruction during metacholine challenge test.
Aronsson D; Tufvesson E; Ankerst J; Bjermer L
Clin Physiol Funct Imaging; 2008 Mar; 28(2):81-5. PubMed ID: 18034849
[TBL] [Abstract][Full Text] [Related]
7. Airway hyperresponsiveness: a comparative study of methacholine and exercise challenges in seasonal allergic rhinitis with or without asthma.
Sin BA; Yildiz OA; Dursun AB; Misirligil Z; Demirel YS
J Asthma; 2009 Jun; 46(5):486-91. PubMed ID: 19544170
[TBL] [Abstract][Full Text] [Related]
8. FEF(25-75) might be a predictive factor for bronchial inflammation and bronchial hyperreactivity in adolescents with allergic rhinitis.
Ciprandi G; Tosca MA; Castellazzi AM; Cairello F; Salpietro C; Arrigo T; Miraglia Del Giudice M
Int J Immunopathol Pharmacol; 2011 Oct; 24(4 Suppl):17-20. PubMed ID: 22032781
[TBL] [Abstract][Full Text] [Related]
9. Screening spirometry to detect respiratory allergy.
Cirillo I; Klersy C; Marseglia G; Tosca M; Ciprandi G
Eur Ann Allergy Clin Immunol; 2006 May; 38(5):146-8. PubMed ID: 17058845
[TBL] [Abstract][Full Text] [Related]
10. Bronchial hyperreactivity in patients with allergic rhinitis: forced expiratory flow between 25 and 75% of vital capacity might be a predictive factor.
Ciprandi G; Tosca MA; Signori A; Cirillo I
Allergy Asthma Proc; 2011; 32(2):4-8. PubMed ID: 21439158
[TBL] [Abstract][Full Text] [Related]
11. Lower respiratory tract complications during nasal provocation: nonspecific stimulant or specific allergen?
Kirmaz C; Degirmenci PB; Tunali D; Yuksel H
Ann Allergy Asthma Immunol; 2007 Jun; 98(6):524-32. PubMed ID: 17601264
[TBL] [Abstract][Full Text] [Related]
12. Bronchial hyperreactivity and spirometric impairment in patients with allergic rhinitis.
Cirillo I; Vizzaccaro A; Tosca MA; Negrini S; Negrini AC; Marseglia G; Ciprandi G
Monaldi Arch Chest Dis; 2005 Jun; 63(2):79-83. PubMed ID: 16128221
[TBL] [Abstract][Full Text] [Related]
13. Effect of cetirizine on bronchial hyperresponsiveness in patients with seasonal allergic rhinitis and asthma.
Aubier M; Neukirch C; Peiffer C; Melac M
Allergy; 2001 Jan; 56(1):35-42. PubMed ID: 11167350
[TBL] [Abstract][Full Text] [Related]
14. Allergic rhinitis with or without concomitant asthma: difference in perception of dyspnoea and levels of fractional exhaled nitric oxide.
Aronsson D; Tufvesson E; Bjermer L
Clin Exp Allergy; 2005 Nov; 35(11):1457-61. PubMed ID: 16297142
[TBL] [Abstract][Full Text] [Related]
15. Early bronchial airflow impairment in patients with persistent allergic rhinitis and bronchial hyperreactivity.
Ciprandi G; Cirillo I; Vizzaccaro A; Monardo M; Tosca MA
Respir Med; 2005 Dec; 99(12):1606-12. PubMed ID: 16291083
[TBL] [Abstract][Full Text] [Related]
16. Bronchial responsiveness to adenosine 5'-monophosphate (AMP) and methacholine differ in their relationship with airway allergy and baseline FEV(1).
De Meer G; Heederik D; Postma DS
Am J Respir Crit Care Med; 2002 Feb; 165(3):327-31. PubMed ID: 11818315
[TBL] [Abstract][Full Text] [Related]
17. Role of forced expiratory flow at 25-75% as an early marker of small airways impairment in subjects with allergic rhinitis.
Marseglia GL; Cirillo I; Vizzaccaro A; Klersy C; Tosca MA; La Rosa M; Marseglia A; Licari A; Leone M; Ciprandi G
Allergy Asthma Proc; 2007; 28(1):74-8. PubMed ID: 17390762
[TBL] [Abstract][Full Text] [Related]
18. Role of FEF25%-75% as a predictor of bronchial hyperreactivity in allergic patients.
Cirillo I; Klersy C; Marseglia GL; Vizzaccaro A; Pallestrini E; Tosca M; Ciprandi G
Ann Allergy Asthma Immunol; 2006 May; 96(5):692-700. PubMed ID: 16729782
[TBL] [Abstract][Full Text] [Related]
19. Eosinophilic inflammation, remodeling of lower airway, bronchial responsiveness and cough reflex sensitivity in non-asthmatic subjects with nasal allergy.
Hara J; Fujimura M; Myou S; Furusho S; Abo M; Oribe Y; Ohkura N; Herai Y; Sone T; Waseda Y; Yasui M; Kasahara K
Int Arch Allergy Immunol; 2006; 140(4):327-33. PubMed ID: 16757921
[TBL] [Abstract][Full Text] [Related]
20. Methacholine dry powder inhaler as a new tool for bronchial challenge test.
Colombo G; Terzano C; Colombo P; Petroianni A; Ricci A; Buttini F
Int J Pharm; 2008 Mar; 352(1-2):165-71. PubMed ID: 18055141
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
